arrow
Back
K

Kamran Badizadegan

centers for disease control & prevention - usa

51H-index
167Paper Count
1.4WCitation Count
Published Papers 74
Publication Date
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
errLANCET
IF88.5
err2024-05-01
err26
errOAAI
errShattock, Andrew J.; Johnson, Helen C.; Sim, So Yoon; Carter, Austin; Lambach, Philipp; Hutubessy, Raymond C. W.; Thompson, Kimberly M.; Badizadegan, Kamran; Lambert, Brian; Ferrari, Matthew J.; Jit, Mark; Fu, Han; Silal, Sheetal P.; Hounsell, Rachel A.; White, Richard G.; Mosser, Jonathan F.; Gaythorpe, Katy A. M.; Trotter, Caroline L.; Lindstrand, Ann; O'Brien, Katherine L.; Bar-Zeev, Naor
errShare
errSave
Modeling undetected poliovirus circulation following the 2022 outbreak in the United States
err2024-01-04
err5
errOAAI
errKalkowska, Dominika A.; Badizadegan, Kamran; Routh, Janell A.; Burns, Cara C.; Rosenberg, Eli S.; Brenner, I. Ravi; Zucker, Jane R.; Langdon-Embry, Marisa; Thompson, Kimberly M.
errShare
errSave
Oral polio vaccine stockpile modeling: insights from recent experience
err2023-09-29
err5
errOAAI
errThompson, Kimberly M.; Kalkowska, Dominika A.; Badizadegan, Kamran
errShare
errSave
Modeling Poliovirus Transmission and Responses in New York State
err2023-08-19
err10
errOAAI
errThompson, Kimberly M.; Kalkowska, Dominika A.; Routh, Janell A.; Brenner, I. Ravi; Rosenberg, Eli S.; Zucker, Jane R.; Langdon-Embry, Marisa; Sugerman, David E.; Burns, Cara C.; Badizadegan, Kamran
errShare
errSave
Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame
err2023-08-14
err2
errOAAI
errBadizadegan, Kamran; Kalkowska, Dominika A.; Thompson, Kimberly M.
errShare
errSave
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission
err2023-06-21
err5
errOAAI
errKalkowska, Dominika A.; Wiesen, Eric; Wassilak, Steven G. F.; Burns, Cara C.; Pallansch, Mark A.; Badizadegan, Kamran; Thompson, Kimberly M.
errShare
errSave
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences
err2023-06-21
err9
PREAI
errKalkowska, Dominika A.; Wassilak, Steven G. F.; Wiesen, Eric; Burns, Cara C.; Pallansch, Mark A.; Badizadegan, Kamran; Thompson, Kimberly M.
errShare
errSave
Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036
err2022-10-05
err7
errOAAI
errThompson, Kimberly M.; Kalkowska, Dominika A.; Badizadegan, Kamran
errShare
errSave
Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan
err2022-06-23
err6
errOAAI
errKalkowska, Dominika A.; Badizadegan, Kamran; Thompson, Kimberly M.
errShare
errSave
errShare
errSave
Polio by the Numbers-A Global Perspective
err2022-04-13
err19
errOAAI
errBadizadegan, Kamran; Kalkowska, Dominika A.; Thompson, Kimberly M.
errShare
errSave
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain
err2020-11-10
err34
errOAAI
errKalkowska, Dominika A.; Pallansch, Mark A.; Wilkinson, Amanda; Bandyopadhyay, Ananda S.; Konopka-Anstadt, Jennifer L.; Burns, Cara C.; Oberste, M. Steven; Wassilak, Steven G. F.; Badizadegan, Kamran; Thompson, Kimberly M.
errShare
errSave
A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID-19 in the United States
err2020-10-20
err18
errOAAI
errThompson, Kimberly M.; Kalkowska, Dominika A.; Badizadegan, Kamran
errShare
errSave